QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • FDA to Review Fibrocell Science, Inc.’s (FCSC.OB) Complete Response Submission for Azficel-T 1 comment
    Jan 12, 2011 2:27 PM | about stocks: FCSC

    Fibrocell Science, Inc., a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced this morning that the U.S. Food & Drug Administration (FDA) has accepted for review its complete response submission for azficel-T, proposed brand name laViv®. The product is designed to treat moderate to severe nasolabial folds and wrinkles. The Prescription Drug User Fee Act (PDUFA) date has been set for June 22, 2011.

    “We are pleased that our complete response was accepted and look forward to working closely with the FDA through the review process,” stated David Pernock, Fibrocell Science Chairman and CEO. “If approved, azficel-T will be the first and only personalized cell-based aesthetic treatment.”

    The company’s unique approach results in a replenishment of the patient’s own fibroblasts, the cells responsible for releasing collagen, elastin and hyaluronic acid to add strength and elasticity to the skin. Fibrocell Science anticipates conducting studies in additional areas such as further aesthetic applications and for treatment of restrictive burn scars, acne scars, and periodontal disease.

    Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net

    Stocks: FCSC
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • BigRIg
    , contributor
    Comments (81) | Send Message
    Love this situation. Selling into spas and derm clinics, plastic surgeons...what's not to like?
    21 May 2011, 07:05 PM Reply Like
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.